Gastroschisis Clinical Trial
Official title:
Developing and Implementing an Interventional Bundle to Reduce Mortality From Gastroschisis in Low-Resource Settings
This study is a multi-centre interventional study at seven tertiary paediatric surgery centres in Ghana, Zambia, Malawi and Tanzania aimed at reducing mortality from gastroschisis.
Background: Gastroschisis has a great disparity in outcomes globally with less than 4%
mortality in high-income countries (HICs) and over 90% mortality in many tertiary paediatric
surgery centres across sub-Saharan Africa (SSA), including the study centres. Low-technology,
cost-effective, evidence-based interventions are available with the potential for improved
outcomes in low-resource settings.
Aim: To develop, implement and prospectively evaluate an interventional care bundle to reduce
mortality from gastroschisis in seven tertiary paediatric surgery centres across SSA.
Study Design: A hybrid type 2 effectiveness-implementation study design will be utilised,
which focusses equally on the effectiveness of the intervention through analysing clinical
outcomes and effectiveness of the implementation through analysis of service delivery and
implementation outcomes.
Methods: Using current literature an evidence-based, low-technology interventional care
bundle has been developed with both pre-hospital and in-hospital components. During 2018 a
systematic review, qualitative study and Delphi process will provide further evidence in
order to optimise the interventional bundle and implementation strategy for use in
low-resource environments. The interventional care bundle has core components, which will
remain consistent across the seven sites, and adaptable components, which will be determined
through in-country co-development meetings with all relevant members of the
multi-disciplinary team. Across the seven study sites it is estimated that 180-289 patients
will be included in the study, which has the potential to determine a difference in pre- and
post-intervention mortality between 10-15%.
Implementation will take place over a 4-week period at each of the study sites between April
- December 2019. Pre- and post-interventional data will be collected on clinical, service
delivery and implementation outcomes between September 2018 to October 2020 (2-years of
patient recruitment at each site with a 30-day post primary intervention follow-up period).
The primary clinical outcome will be all-cause, in-hospital mortality. Secondary outcomes
include the occurrence of a major complication, length of hospital stay and time to full
enteral feeds. Service delivery outcomes include time to hospital and primary intervention
and adherence to the pre-hospital and in-hospital management protocols. Implementation
outcomes will include acceptability, adoption, appropriateness, feasibility, fidelity,
coverage, cost and sustainability.
Expected Results: Pre- and post-intervention clinical outcomes will be compared using
Chi-squared analysis, unpaired t-test and/ or Mann-Whitney test. Time-series analysis will be
undertaken using Statistical Process Control to identify significant trends and shifts in
outcome overtime. Multivariate logistic regression analysis will be used to identify both
clinical and implementation factors affecting outcome with adjustment for confounders. P<0.05
will be deemed significant.
Outcome: This will be the first multi-centre interventional study to the investigator's
knowledge aimed at reducing mortality from gastroschisis in low-resource settings. If
successful, detailed evaluation of both the clinical and implementation components of the
study will allow sustainability in the study sites and further scale-up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00539292 -
Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis
|
Phase 2 | |
Recruiting |
NCT01469208 -
Music Therapy: An Adjunct To Gastroschisis Infants' Care
|
N/A | |
Terminated |
NCT00404690 -
Bedside Silo Versus Operative Closure for Gastroschisis
|
N/A | |
Recruiting |
NCT05704257 -
Fetal Repair of Complex Gastroschisis: A Safety and Feasibility Trial
|
N/A | |
Completed |
NCT03533439 -
Regional Blood Saturation Levels in Gastroschisis
|
||
Active, not recruiting |
NCT03393832 -
Oral Care in Infants With Gastroschisis
|
||
Completed |
NCT03666767 -
Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
|
||
Terminated |
NCT03355326 -
Evaluation of Glycerin Suppositories to Improve Bowel Function in Gastroschisis
|
Phase 4 | |
Completed |
NCT03185637 -
Children's Surgery in Sub-Saharan Africa
|
N/A | |
Completed |
NCT02575846 -
Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair
|
N/A | |
Terminated |
NCT01094587 -
Sutureless vs Sutured Gastroschisis Closure
|
N/A | |
Active, not recruiting |
NCT00127946 -
Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses
|
Phase 3 | |
Withdrawn |
NCT04186039 -
Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations
|
N/A | |
Active, not recruiting |
NCT06461325 -
Surgical Management Of Gastroschisis
|
||
Completed |
NCT03960320 -
Health Related Quality of Life of Patients With Abdominal Wall Defects
|
||
Terminated |
NCT02098915 -
Metoclopramide Pilot Trial
|
Phase 3 | |
Completed |
NCT01316510 -
Probiotics in Infants With Gastroschisis
|
N/A | |
Completed |
NCT04020939 -
The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.
|
N/A | |
Recruiting |
NCT06072976 -
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
|
N/A | |
Recruiting |
NCT05293353 -
Neokare Safety and Tolerability Assessment in Neonates With GI Problems
|